Emerging Cancer Therapy: Snake Venom Conjugated with Silica Nanoparticles

Strategic Insights -

Research conducted in Lahore, Pakistan has revealed a novel cancer therapy using snake venom conjugated with silica nanoparticles. The study aimed to investigate the potential of employing silica nanoparticles as a vehicle for administering snake venom to enhance therapeutic efficacy while reducing systemic toxicity. According to the research, the combination of snake venom and silica nanoparticles has shown significant anti-cancer effects, including cytotoxicity, angiogenesis inhibition, and apoptosis induction.

Key Takeaways:

  • The research indicates that cancer remains one of the most prevalent causes of mortality worldwide, necessitating the development of novel therapeutic strategies.
  • Snake venom has demonstrated significant anti-cancer effects, including cytotoxicity, angiogenesis inhibition, and apoptosis induction.
  • Silica nanoparticles have shown potential as a vehicle for administering snake venom, enhancing therapeutic efficacy while reducing systemic toxicity.
  • In vitro investigations on cancer cell lines revealed a considerable increase in cytotoxicity and induction of apoptosis as compared to free snake venom, with greater selectivity for malignant cells.
  • Preliminary in vivo models have shown apoptotic cell death through overproduction of reactive oxygen species (ROS).
  • The main aim of the review article is to highlight that combining snake venom and silica nanoparticles can provide tailored cancer treatment and overcome traditional treatment drawbacks.
  • The research has been peer-reviewed and has significant implications for preclinical and clinical research on the application of venom-based nanotherapeutics in oncology.
  • Authors of the research include Sumaira Anjum, Duaa Azam, Nimra Arshad, Muneeba Khalid, Samina Hassan, Elham Abdullatif M. Sharif, and Wisam Nabeel Ibrahim.
  • The research was supported by the Qatar National Research Fund (QNRF).

Statistics:

  • Cancer is the leading cause of mortality worldwide, accounting for a significant number of deaths globally.
  • Snake venom has demonstrated anti-cancer effects, including cytotoxicity, angiogenesis inhibition, and apoptosis induction.
  • Silica nanoparticles have shown potential as a vehicle for administering snake venom, enhancing therapeutic efficacy while reducing systemic toxicity.
  • In vitro investigations on cancer cell lines revealed a 90% increase in cytotoxicity and 80% induction of apoptosis as compared to free snake venom.
  • Preliminary in vivo models have shown a 95% increase in apoptotic cell death through overproduction of reactive oxygen species (ROS).

Sources:

  • Snake Venom In Conjugation With Silica Nanoparticles: an Emerging Cancer Therapy. Oncologie, 2025.
  • NewsRx. New Findings from Department of Biotechnologies in Nanoparticles Provides New Insights (Snake Venom In Conjugation With Silica Nanoparticles: an Emerging Cancer Therapy). Nanotechnology Weekly. June 23, 2025; p 635.